LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (HKG:2291)
Hong Kong
· Delayed Price · Currency is HKD 11.72
+0.04 (0.34%)
Apr 29, 2026, 4:08 PM HKT
HKG:2291 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Operating Revenue | 527.47 | 471.14 | 325.9 | 247.67 | 222.58 | Upgrade
|
| Other Revenue | 0.47 | 0.5 | 0.73 | - | - | Upgrade
|
| Revenue | 527.94 | 471.64 | 326.62 | 247.67 | 222.58 | Upgrade
|
| Revenue Growth (YoY) | 11.94% | 44.40% | 31.88% | 11.27% | 50.14% | Upgrade
|
| Cost of Revenue | 80.99 | 47.61 | 37.53 | 27.98 | 25.04 | Upgrade
|
| Gross Profit | 446.95 | 424.03 | 289.09 | 219.69 | 197.55 | Upgrade
|
| Selling, General & Admin | 134.92 | 106.77 | 87.5 | 71.91 | 70.26 | Upgrade
|
| Research & Development | 58.15 | 57.99 | 62.07 | 53.87 | 41.39 | Upgrade
|
| Other Operating Expenses | -5.22 | -3.27 | -7.37 | -17.74 | -10.78 | Upgrade
|
| Operating Expenses | 190.15 | 168.47 | 136.21 | 113.72 | 101.8 | Upgrade
|
| Operating Income | 256.81 | 255.56 | 152.88 | 105.97 | 95.75 | Upgrade
|
| Interest Expense | -0.12 | -0.16 | -0.14 | -18.97 | -11.55 | Upgrade
|
| Interest & Investment Income | 23.48 | 28.84 | 25.58 | 5.67 | 7.85 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 1.96 | -5.89 | -82.28 | 5.19 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.71 | -0.14 | 0.6 | -0.05 | 1.47 | Upgrade
|
| EBT Excluding Unusual Items | 276.46 | 286.06 | 173.04 | 10.34 | 98.72 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -4.93 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0.03 | - | - | - | Upgrade
|
| Asset Writedown | - | - | - | -0 | -0 | Upgrade
|
| Other Unusual Items | - | - | - | -20.44 | -32.69 | Upgrade
|
| Pretax Income | 276.46 | 286.09 | 173.04 | -15.03 | 66.03 | Upgrade
|
| Income Tax Expense | 36.74 | 40.53 | 21.66 | 4.78 | 7.33 | Upgrade
|
| Net Income | 239.73 | 245.56 | 151.38 | -19.81 | 58.7 | Upgrade
|
| Net Income to Common | 239.73 | 245.56 | 151.38 | -19.81 | 58.7 | Upgrade
|
| Net Income Growth | -2.38% | 62.22% | - | - | -14.65% | Upgrade
|
| Shares Outstanding (Basic) | 347 | 347 | 347 | 328 | 304 | Upgrade
|
| Shares Outstanding (Diluted) | 347 | 347 | 347 | 328 | 304 | Upgrade
|
| Shares Change (YoY) | - | - | 5.86% | 7.79% | 9.63% | Upgrade
|
| EPS (Basic) | 0.69 | 0.71 | 0.44 | -0.06 | 0.19 | Upgrade
|
| EPS (Diluted) | 0.69 | 0.71 | 0.44 | -0.06 | 0.19 | Upgrade
|
| EPS Growth | -2.57% | 62.22% | - | - | -22.14% | Upgrade
|
| Free Cash Flow | - | 137.05 | 66.75 | 52.25 | 82.83 | Upgrade
|
| Free Cash Flow Per Share | - | 0.40 | 0.19 | 0.16 | 0.27 | Upgrade
|
| Dividend Per Share | 0.500 | 0.620 | 0.570 | - | - | Upgrade
|
| Dividend Growth | -19.36% | 8.77% | - | - | - | Upgrade
|
| Gross Margin | 84.66% | 89.91% | 88.51% | 88.70% | 88.75% | Upgrade
|
| Operating Margin | 48.64% | 54.19% | 46.81% | 42.79% | 43.02% | Upgrade
|
| Profit Margin | 45.41% | 52.06% | 46.35% | -8.00% | 26.37% | Upgrade
|
| Free Cash Flow Margin | - | 29.06% | 20.44% | 21.10% | 37.21% | Upgrade
|
| EBITDA | 278.14 | 276.89 | 158.89 | 117.99 | 103.88 | Upgrade
|
| EBITDA Margin | 52.68% | 58.71% | 48.65% | 47.64% | 46.67% | Upgrade
|
| D&A For EBITDA | 21.33 | 21.33 | 6.01 | 12.02 | 8.13 | Upgrade
|
| EBIT | 256.81 | 255.56 | 152.88 | 105.97 | 95.75 | Upgrade
|
| EBIT Margin | 48.64% | 54.19% | 46.81% | 42.79% | 43.02% | Upgrade
|
| Effective Tax Rate | 13.29% | 14.17% | 12.52% | - | 11.10% | Upgrade
|
| Revenue as Reported | 527.94 | 471.64 | 326.62 | - | - | Upgrade
|
| Advertising Expenses | - | 3.25 | 3.19 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.